Arcus Biosciences Earnings Review: Q4 Summary
Benzinga Insights 8 months ago
Earnings
Arcus Biosciences (NYSE:RCUS) announced its Q4 earnings on Wednesday, February 25, 2026 at 04:05 PM.
Here's a breakdown of the earnings report.
Earnings
Arcus Biosciences beat estimated earnings by 18.35%, reporting an EPS of $-0.89 versus an estimate of $-1.09.
Revenue was down $3.00 million from the same period last year.
Historical Earnings Summary
The company beat on EPS by $0.04 in the last quarter, resulting in a 2.06% increase share price change the following day.
Here's a look at Arcus Biosciences's past performance:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -1.31 | -1.160 | -1.01 | -1.20 |
| EPS Actual | -1.27 | 0.001 | -1.14 | -1.03 |
| Revenue Estimate | 20.33M | 28.95M | 38.61M | 29.38M |
| Revenue Actual | 26.00M | 160.00M | 28.00M | 36.00M |
To track all earnings releases for Arcus Biosciences visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.